Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > DxTm

<< Previous

Bullboard Posts

Next >>

Post by RazeKreationson Aug 10, 2023 4:45pm

239 Views

Post# 35582627

DxTm

What happened to all the sales of Vtm. 50 million dollars worth imported in 2019 and no one is interested in a domestic supplier? How much more inventory is going to need to be written off? Is it no good? Is it too expensive? No attempt to sell to anyone other than Ontario? Why did Ontario stop buying? Questions that need an answer. Can anyone explain the situation?

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages